Participation of NIAID in FOA DA-13-003 Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P50)

Notice Number: NOT-AI-12-057

Key Dates
Release Date: September 21, 2012

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

This Notice is to inform applicants that the National Institute of Allergy and Infectious Diseases (NIAID) has joined the funding opportunity announcement RFA-DA-13-003, entitled “Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P50)”, effective immediately.

The Components of Participating Organizations section of RFA-DA-13-003 (P50) has been revised to include NIAID:

National Institute on Drug Abuse (NIDA)
National Cancer Institute (NCI)
National Heart, Lung and Blood Institute (NHLBI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
Center for Tobacco Products (CTP) (FDA)

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Dr. Lynda Chiodetti
Program Officer
National Institute of Allergy and Infectious Diseases (NIAID)
6700B Rockledge Dr.
RM 2110 MSC 7614
Bethesda, MD 20892-7614
Telephone: 301-451-3119
Email: lchiodetti@niaid.nih.gov

Financial/Grants Management Contact(s)

Deanna Ingersoll
Grants Management Specialist, Grant Management Program
National Institute of Allergy and Infectious Diseases (NIAID)
6700B Rockledge Dr.
RM 2110 MSC 7614
Bethesda, MD 20892-7614
Telephone: 301-594-2686
Email: ingersolld@niaid.nih.gov